Cheryl Gault
Direttore operativo presso Rapport Therapeutics, Inc.
Posizioni attive di Cheryl Gault
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Direttore operativo | 07/09/2023 | - |
Storia della carriera di Cheryl Gault
Precedenti posizioni note di Cheryl Gault
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direttore operativo | 01/01/2021 | 28/07/2023 |
| Corporate Officer/Principal | 01/05/2020 | 01/01/2021 | |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2011 | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Vendite & Marketing | - | - |
Formazione di Cheryl Gault
| Boston College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Cheryl Gault
- Esperienza
